This podcast episode explores the development and impact of GLP-1 medications, specifically focusing on their efficacy in treating obesity and diabetes. The sections highlight the journey of drugs like Mounjaro, Laraglitide, Ozempic, and Wigovi, shedding light on the challenges faced during their development and the positive outcomes they have achieved. The episode also addresses the issue of high drug prices, which hinders patient access to these medications. Overall, the podcast emphasizes the potential of GLP-1 medications to transform the treatment of obesity and diabetes, while also recognizing the affordability barriers that need to be addressed.
